Could clinical diffusion-mismatch determined using DWI ASPECTS predict neurological improvement after thrombolysis before 3 h after acute stroke?

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 81, Issue 8, 2010, Pages 864-868

  Terasawa, Yuka ^a,b   Kimura, Kazumi ^a   Iguchi, Yasuyuki ^a   Kobayashi, Kazuto ^a   Aoki, Junya ^a   Shibazaki, Kensaku ^a   Kaji, Ryuji ^b  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT;

AGED; ALBERTA STROKE PROGRAM EARLY CT SCORE; ARTICLE; BRAIN SIZE; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; FIBRINOLYTIC THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PREDICTION; PRIORITY JOURNAL; RANKIN SCALE; SCORING SYSTEM; STROKE; TREATMENT OUTCOME; BRAIN ISCHEMIA; CLASSIFICATION; COMPLICATION; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PATHOLOGY; PREDICTIVE VALUE; PROSPECTIVE STUDY; RISK FACTOR;

AGED; BRAIN ISCHEMIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PLATELET AGGREGATION INHIBITORS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 77955735965     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2009.190140     Document Type: Article

References (14)

1. Davalos A, Blanco M, Pedraza S, et al. The clinical-dwi mismatch: a new diagnostic approach to the brain tissue at risk of infarction. Neurology 2004;62:2187-92. (Pubitemid 38787773)
2. Prosser J, Butcher K, Allport L, et al. Clinical-diffusion mismatch predicts the putative penumbra with high specificity. Stroke 2005;36:1700-4. (Pubitemid 41098765)
3. Reineck LA, Agarwal S, Hillis AE. 'Diffusion-clinical mismatch' Is associated with potential for early recovery of aphasia. Neurology 2005;64:828-33.
4. Barber PA, Demchuk AM, Zhang J, et al. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. Aspects study group. Alberta stroke programme early ct score. Lancet 2000;355:1670-4.
5. Barber PA, Hill MD, Eliasziw M, et al. Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging. J Neurol Neurosurg Psychiatry 2005;76:1528-33. (Pubitemid 41531700)
6. Yamaguchi T, Mori E, Minematsu K, et al. Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan alteplase clinical trial (j-act). Stroke 2006;37:1810-15. (Pubitemid 44297734)
7. Kimura K, Iguchi Y, Shibazaki K, et al. Recanalization between 1 and 24 hours after t-pa therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients. J Neurol Sci 2008;270:48-52.
8. Iguchi Y, Kimura K, Kobayashi K, et al. Ischaemic stroke with malignancy may often be caused by paradoxical embolism. J Neurol Neurosurg Psychiatry 2006;77:1336-9. (Pubitemid 44851991)
9. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Toast. Trial of org 10172 in acute stroke treatment. Stroke 1993;24:35-41.
10. Terasawa Y, Iguchi Y, Kimura K, et al. Neurological deterioration in small vessel disease may be associated with increase of infarct volume. J Neurol Sci 2008;269:35-40.
11. Lansberg MG, Thijs VN, Hamilton S, et al. Evaluation of the clinical-diffusion and perfusion-diffusion mismatch models in defuse. Stroke 2007;38:1826-30. (Pubitemid 46847254)
12. Tei H, Uchiyama S, Usui T. Clinical-diffusion mismatch defined by nihss and aspects in non-lacunar anterior circulation infarction. J Neurol 2007;254:340-6. (Pubitemid 46399196)
13. Ebinger M, Iwanaga T, Prosser JF, et al. Clinical-diffusion mismatch and benefit from thrombolysis 3 to 6 hours after acute stroke. Stroke 2009;40:2572-4.
14. Kimura K, Iguchi Y, Shibazaki K, et al. Large ischemic lesions on diffusion-weighted imaging done before intravenous tissue plasminogen activator thrombolysis predicts a poor outcome in patients with acute stroke. Stroke 2008;39:2388-91.